Navigation Links
Cardica's C-Port Anastomosis Systems Facilitate Beating Heart Bypass Surgery in Study
Date:4/21/2008

of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port systems are marketed in Europe and the United States. The PAS-Port(R) Proximal Anastomosis System is marketed in Europe and Japan and is being evaluated currently in a pivotal trial in the United States and Europe. Cardica also is developing additional devices with Cook Medical to facilitate vascular closure and other surgical procedures.

Forward-Looking Statements

This press release contains forward-looking statements, including, without limitation, statements related to the potential cost savings and improved patient outcomes from future use of C-Port systems and the potential of C-Port systems in the field of cardiothoracic surgery. The words "believe," "will" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Cardica's current expectations. Forward-looking statements involve risks and uncertainties. Cardica's actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks associated with the long-term patency of graft vessels connected using the C-Port systems, market acceptance of Cardica's C-Port systems, manufacturing of the C-Port systems and its suppliers, Cardica's sales, marketing and distribution strategy and capabilities. These and other risk factors are discussed under "Risk Factors" in Cardica's Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2007. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read the Company's reports filed with the U.S. Securities and Exchange Commission, available at http://www.sec.gov.


'/>"/>
SOURCE Cardica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cardicas C-Port Anastomosis Systems for Coronary Artery Bypass Graft Procedures to be Used to Train Cardiothoracic Surgeons at Society of Thoracic Surgeons (STS) University
2. Four Rivers Software Systems Delivers TMS WorkGroup 2008.3.3
3. ACS Systems Improving Delivery of Healthcare in Malta
4. Perot Systems Selected to Implement Revenue Cycle Solution for New York Downtown Hospital
5. Open Biosystems Launches Decode RNAi Viral Screening Pools for Low-Cost Genome-Scale RNAi Screens
6. Health Monitoring Systems Releases EpiCenter(TM)
7. Boothwyn Pharmacy, a Pioneer Provider of Medication Adherence Services, to Market and Sell InforMedixs Med-ePhone(TM) and Med-eMonitor(TM) Systems
8. Samplify Systems Announces Availability of Samplify for Windows Release 2.6, and Samplify for Windows Embedded Edition, Transforming RF Data Recording Applications with X-COM Systems
9. Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the First Quarter Ended March 31, 2008
10. Alsius Corporation Awarded Three-Year Agreement With MedAssets Supply Chain Systems
11. New Version of Microsoft Amalga Now Available to Hospitals and Health Systems
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Employees with workplace flexibility have healthier lifestyle habits 2Health News:Cardica Announces Exercise of Over-Allotment Option 2Health News:Cardica Announces Exercise of Over-Allotment Option 3Health News:RNs Sponsor Hard-Hitting Health Care Ads in Top 10 Iowa Papers 2Health News:Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia 2Health News:Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia 3Health News:Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia 4Health News:Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia 5Health News:Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia 6Health News:Advanced Clinical Research Services Enhances Biostatistics Offering 2